Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model.

Capacio, Benedict A; Shankara Narayanan, Jayanth S; Vicente, Diego A; Liu, Yujia; LaPorte, Jason P; Cox, Bryan F; Jaroch, David B; Katz, Steven C; White, Rebekah R

Capacio, Benedict A; Shankara Narayanan, Jayanth S; Vicente, Diego A; Liu, Yujia; LaPorte, Jason P; Cox, Bryan F; Jaroch, David B; Katz, Steven C; White, Rebekah R.

Affiliation

Capacio BA; Uniformed Services University of Health Sciences, Bethsda, MD.
Shankara Narayanan JS; Department of Surgery, Moores Cancer Center, University of California San Diego, CA.
Vicente DA; Uniformed Services University of Health Sciences, Bethsda, MD.
Liu Y; TriSalus Life Sciences, Westminster, CO.
LaPorte JP; TriSalus Life Sciences, Westminster, CO.
Cox BF; TriSalus Life Sciences, Westminster, CO.
Jaroch DB; TriSalus Life Sciences, Westminster, CO.
Katz SC; TriSalus Life Sciences, Westminster, CO; Department of Surgery, Brown University Warren Alpert Medical School, Providence, RI.
White RR; Department of Surgery, Moores Cancer Center, University of California San Diego, CA. Electronic address: rewhite@health.ucsd.edu.

Surgery ; 174(3): 666-673, 2023 09.

Article de En | MEDLINE | ID: mdl-37391328

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Carcinome du canal pancréatique Limites: Animals Langue: En Journal: Surgery Année: 2023 Type de document: Article Pays d'affiliation: Moldavie Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google